Heterogeneity of vascular cells in different breast cancer subtypes revealed by single-cell RNA-seq analysis

Lei Xia

doi:10.54097/hset.v36i.6261

Authors

Lei Xia

DOI:

https://doi.org/10.54097/hset.v36i.6261

Keywords:

Breast Cancer, ScRNA-seq Technology, Vasculature, Endothelial Cells.

Abstract

Breast cancer is a common type of malignant tumor developing from breast tissue that happens in women, which can be triggered by both genetic and environmental factors. Nowadays, it is increasing recognized as a global public health problem. Despite some treatments have been used, there are still many challenges in treating breast cancer due to the recurrence and metastasis. The development of single-cell RNA sequencing (scRNA-seq) technology has shown great potential in deeply discovering the molecular mechanism of breast cancer. In this study, we processed scRNA-seq data of patients from different types of breast cancer subtypes, extracted and integrated the vascular cells, and found a distinct tumor-specific endothelial cell. The results not only showed the power of meta-analysis of existing single-cell data, but also revealed the detailed characteristics of vascular cells in different conditions, yielding light to future medical treatments in breast cancer.

Downloads

Download data is not yet available.

References

Ren et al. Single cell RNA sequencing for breast cancer: present and future, Cell Death Discovery, 1, 5 (2021).

Nguyen, Q. H. et al. Profifiling human breast epithelial cells using single cell RNA sequencing identififies cell diversity. Nat. Commun. 9, 2028 (2018).

Brady, S. W. et al. Combating subclonal evolution of resistant cancer phenotypes. Nat. Commun. 8, 1231 (2017).

Kim, C. et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173, 879 – 893 (2018).

Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704 – 715 (2008).

Vereecke, L., Beyaert, R. & van Loo, G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30, 383 – 391 (2009).

Tong, M. et al. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells. Cancer Commun. 38, 56 (2018).

Pal et al. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast, 1, (2021).

Cheung et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14 - expressing tumor cell clusters, Cell Biology, 2, 5 (2016).

Moreno et al. IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity, Neoplasia, 3, 7 (2013).